Article info

Extended report
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Authors

  1. Correspondence to Professor Maria-Antonietta D'Agostino, Université Versailles Saint Quentin en Yvelines, AP-HP Ambroise Paré Hospital, 9 Avenue Charles de Gaulle, Boulogne-Billancourt 92100, France; maria-antonietta.dagostino{at}apr.aphp.fr
View Full Text

Citation

D'Agostino M, Wakefield RJ, Berner-Hammer H on behalf of the OMERACT-EULAR-Ultrasound Task Force, et al
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Publication history

  • Received April 1, 2015
  • Revised October 21, 2015
  • Accepted October 25, 2015
  • First published November 20, 2015.
Online issue publication 
September 09, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.